ranbaxy (CreditSuisse) What's depressing Ranbaxy's current margins?

ESOPs: An aggressive new policy; would be dilutive; Synergy tracker between Ranbaxy and Daiichi;
Date Rating Target Price Recommendation Price Broker house
18 Apr 2011 maintain underperform 450 462 CreditSuisse Report

No comments:

Post a Comment